Wednesday, November 2, 2022
HYPORESOLVE - MEASURING HYPOGLYCEMIA AND ITS IMPACT (1.5 CME Credits)free Recording
7:30
Moderators
David Kerr, MBChB, DM, FRCP, FRCPE
Sansum Diabetes Research Institute, Santa Barbara, California, USA
Michael A. Kohn, MD, MPP
University of California, San Francisco, San Francisco, California, USA
7:30
Overview of HypoMETRICS
Pratik Choudhary, FRCP, MD, MRCP, MBBS
University of Leicester, Leicester, UK
7:45
Developing and Validating the HypoMETRICS App
Natalie Zaremba, MSc
King’s College London, London, UK
8:00
Symptomatic Hypoglycemia in the Age of CGM
Patrick M. Divilly, MB, BAO, BCh, MRCPI
King’s College London, London, UK
8:20
Developing an Objective Tool to Assess Hypoglycaemia Awareness
Gilberte Martine-Edith, PhD
King’s College London, London, UK
8:40
Q&A / Panel Discussion
9:00
Break
ONCE-WEEKLY INSULINS (1.5 CME Credits)free Recording
9:15
Once-Weekly Insulins – Where Are We Now?
Chantal Mathieu, MD, PhD
Catholic University of Leuven, Leuven, Belgium
9:30
Insulin Icodec Basal Switch Trial, ONWARDS 2
Athena Philis-Tsimikas, MD
Scripps Health, San Diego, California, USA
9:50
Insulin Icodec Basal Bolus Trial, ONWARDS 4
Chantal Mathieu, MD, PhD
Catholic University of Leuven, Leuven, Belgium
10:10
Once-Weekly Insulins – What’s Coming?
Harpreet S. Bajaj, MD, MPH, FACE
LMC Healthcare, Brampton, Ontario, Canada
10:25
Q&A / Panel Discussion
10:45
Break
MEET THE PROFESSORS (Non-Accredited Education)
14:00
Peter G. Jacobs, PhD
Oregon Health & Science University, Portland, Oregon, USA
14:30
Mark A. Arnold, PhD
University of Iowa, Iowa City, Iowa, USA
15:00
Steven V. Edelman, MD
University of California, San Diego, San Diego, California, USA
15:30
End of Session
Thursday, November 3, 2022
WORKSHOP A: MEASUREMENT OF GLUCOSE, INSULIN, AND KETONES
PANEL 1: MEASUREMENT OF GLUCOSE (Non-Accredited Education)
What new developments for measuring glucose are most likely to be widely adopted?
8:00
Moderators
John C. Pickup, MA, DPhil, FRCPath
King’s College London School of Medicine, London, UK
Howard Wolpert, MD
Boston Medical Center, Cambridge, Boston, USA
8:05
Development of a Self-Powered Diaper Glucose Sensor Combining a Low Power Wireless Transmission Device and a Paper Substrate Biofuel Cell
Isao Shitanda, PhD
Tokyo University of Science, Noda-shi, Chiba, Japan
8:20
Traceability of CGMs
Guido Freckmann, MD
Institute for Diabetes Technology Research at Ulm University, Ulm, Germany
8:35
Advances in the Noninvasive Sensing of Glucose in People
Mark A. Arnold, PhD
The University of Iowa, Iowa City, Iowa, USA
8:50
Dynamic Interference Testing of CGM Sensors
Andreas Pfützner, MD, PhD
Pfützner Science and Health Institute, Mainz, Germany
9:05
CGM Accuracy - Clinical Trials vs. Real-World Data
Jan S. Krouwer, PhD
Krouwer Counseling, Sherborn, Massachusetts, USA
9:20
Q&A / Panel Discussion
9:45
Break
PANEL 2: MEASUREMENT OF INSULIN AND KETONES (Non-Accredited Education)
What new developments for measuring insulin and ketones are most likely to be widely adopted?
10:10
Moderators
Peter G. Jacobs, PhD
Oregon Health & Science University, Portland, Oregon, USA
Kirsten Nørgaard, MD, DMSc
Steno Diabetes Center Copenhagen, Herlev, Denmark
10:15
Current Technology Development to Realize Continuous Insulin Monitoring System
Koji Sode, PhD
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
10:30
The Development of the Disposable and Highly Reproducible Insulin Sensing Point of Care Technology
Jeffrey T. La Belle, PhD
Grand Canyon University, Phoenix, Arizona, USA
10:45
Microneedle Sensing of Insulin and Ketones
Hazhir Teymourian, PhD
AquilX Inc., San Diego, California, USA
11:00
Continuous Ketone Monitoring Update
Shridhara Alva, PhD
Abbott Diabetes Care, Alameda, California, USA
11:15
Q&A / Panel Discussion
11:40
Lunch
WORKSHOP B: VIRTUAL DIABETES CARE
PANEL 1: TECHNICAL BARRIERS (1.5 CME Credits)
What are the greatest technical barriers to widespread adoption of virtual diabetes care?
12:40
Moderators
Wei-An (Andy) Lee, DO
Los Angeles County + University of Southern California Medical Center, Los Angeles, California, USA
Andreas Pfützner, MD, PhD
Pfützner Science and Health Institute, Mainz, Germany
12:45
Bridging the Telemedicine Divide
Tejaswi Kompala, MD
Teladoc Health; University of California, San Francisco, San Francisco, California, USA
13:00
Technology Literacy
David Kerr, MBChB, DM, FRCP, FRCPE
Sansum Diabetes Research Institute, Santa Barbara, California, USA
13:15
Secure Authentication for Diabetes Devices
Shahid N. Shah, MSc
Netspective Communications LLC, Landover, Maryland, USA
13:30
Cybersecurity of Diabetes Devices
David N. Kleidermacher, BS
Google, Mountain View, California, USA
13:45
Privacy of Diabetes Devices
Randi E. Seigel, JD
Manatt, Phelps & Phillips LLP, New York, New York, USA
14:00
Q&A / Panel Discussion
14:20
Break
PANEL 2: CLINICAL BARRIERS (1.75 CME Credits)
What are the greatest clinical barriers to widespread adoption of virtual diabetes care?
14:45
Moderators
Andjela Drincic, MD
University of Nebraska Medical Center, Omaha, Nebraska, USA
Rosemary G. Oshinsky, RN, CDE, MSN
New Life New U Holistic Diabetes Care, Bethesda, Maryland, USA
14:50
Delivering Diabetes Care in a Direct-to-Consumer Model
Erich S. Huang, MD, PhD
Verily Life Sciences, South San Francisco, California, USA; Duke University School of Medicine, Durham, North Carolina, USA
15:05
Big Data and AI for Adaptive and Individualized Diabetes Management
Pavitra Krishnaswamy, PhD
A*STAR Institute for Infocomm Research, Singapore
15:20
The Evolving Role of Virtual Care During the Pandemic
Ateev Mehrotra, MD, MPH
Harvard Medical School, Boston, Massachusetts, USA
15:35
Delivering Telehealth to a County Hospital Population
Wei-An (Andy) Lee, DO
Los Angeles County + University of Southern California Medical Center, Los Angeles, California, USA
15:50
The Payer Perspective on Telehealth
Jordan Silberman, MD, PhD
Carelon Digital Platforms (part of Elevance Health), Palo Alto, California, USA
16:05
Q&A / Panel Discussion
16:30
End of Workshop
Friday, November 4, 2022
INTRODUCTION (0.5 CME Credits)
8:00
Introduction
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA
8:05
Keynote Presentation: FDA and Diabetes Technology
Jeffrey E. Shuren, MD, JD
Center for Devices and Radiological Health, United States Food and Drug Administration, Silverspring, Maryland, USA
8:25
Q&A
SESSION 1: METRICS FOR MANAGING DIABETES AND PREDICTING OUTCOMES (1.25 CME Credits)
How will CGM data be interpreted in the future?
8:30
Moderators
Viswanathan Mohan, MD, PhD, DSc
Dr. Mohan’s Diabetes Specialities Centre, Chennai, India; Madras Diabetes Research Foundation, Chennai, India
Jennifer L. Sherr, MD, PhD
Yale University, New Haven, Connecticut, USA
8:35
Advances in CGM Data Science
Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia, USA
8:50
The GRI: A New Composite Metric for Assessing the Quality of Glycemia of a CGM
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA
9:05
Statistical Basis for the GRI
Michael A. Kohn, MD, MPP
University of California, San Francisco, San Francisco, California, USA
9:20
CGM Data in People Without Diabetes
Viral N. Shah, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA
9:35
Q&A / Panel Discussion
9:55
End of Session
SESSION 2: INTEGRATION OF CGM DATA INTO THE EHR (1.0 CME Credits)
How can the EHR be improved to better accommodate diabetes data?
9:55
Moderators
Richard M. Bergenstal, MD
International Diabetes Center at Park Nicollet, Minneapolis, Minnesota, USA
Priya Prahalad, MD, PhD
Stanford University, Stanford, California, USA
Presentation of Diabetes Technology Leadership Award
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA
10:00
The Stenopool Database
Christian Selmer, MD, PhD
Steno Diabetes Center Copenhagen, Herlev, Denmark
10:15
iCoDE: A New Standard for Integration of CGM Data into the EHR
Juan Espinoza, MD, FAAP
Children’s Hospital Los Angeles, University of Southern California, Los Angeles, California, USA
10:30
New Tools for Data Management
Mark A. Clements, MD, PhD, CPI, FAAP
Children’s Mercy Hospitals & Clinics, Kansas City, Missouri, USA
10:45
Q&A / Panel Discussion
10:55
Break
SESSION 3: REGULATION OF DIABETES TECHNOLOGY (1.25 CME Credits)
What are the trends in regulation of diabetes technology?
11:20
Moderators
Alexander Fleming, MD
Kinexum, Harpers Ferry, West Virginia, USA
Alberto Gutierrez, PhD
NDA Partners LLC, Bethesda, Maryland, USA
11:25
Regulation of Glucose Monitoring Systems
Yiduo Wu, PhD
United States Food and Drug Administration, Silver Spring, Maryland, USA
11:35
Regulation of Human-in-the-System Features of an Automated Insulin Delivery System
Zane Arp, PhD
United States Food and Drug Administration, Silver Spring, Maryland, USA
11:45
Trends in Digital Health Regulation
Bradley M. Thompson, JD, MBA, MADS
Epstein Becker Green PC, Washington, D.C., USA
11:55
Regulation of Digital Health Tools
Brendan O’Leary, BSME
United States Food and Drug Administration, Silver Spring, Maryland, USA
12:05
Q&A / Panel Discussion
12:25
Lunch
SESSION 4: DIGITAL HEALTH TO NUDGE BEHAVIOR (Non-Accredited Education)
How can digital health tools improve adherence to diabetes treatment?
13:10
Moderators
William T. Cefalu, MD
NIDDK/NIH, Bethesda, Maryland, USA
Victoria C. Hsiao, MD, PhD
University of California, San Francisco, San Francisco, California, USA
13:15
Digital Health Tools to Improve Patient Engagement
Felix Lee, MPharm, MSc, MBA
Sanofi, Bridgewater, New Jersey, USA
13:30
Better Behavior in Diabetes
Matthew E. Kahn, PhD
University of Southern California, Los Angeles, California, USA
13:45
New Metrics and Methods for Delivering Digital Health Interventions
Elizabeth Holt, MD, FACE
LifeScan Global Corporation, Malvern, Pennsylvania, USA
14:00
Behavioral Economics for Improving Adherence
Susana R. Patton, PhD
Nemours Children’s Health, Jacksonville, Florida, USA
14:15
Q&A / Panel Discussion
14:25
End of Session
SESSION 5: ESTIMATING CARBOHYDRATES (Non-Accredited Education)
How can technology estimate food intake by persons with diabetes?
14:25
Moderator
Thanh D. Hoang, DO
Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
14:30
Multimedia Data-Based Mobile Applications for Dietary Assessment
Stavroula G. Mougiakakou, PhD
University of Bern, Bern, Switzerland
14:45
Predicting the Macronutrient Composition of Mixed Meals from Dietary Biomarkers
Ricardo Gutierrez-Osuna, PhD
Texas A&M University, College Station, Texas, USA
15:00
Sensors for Detecting Food Intake
Samantha Kleinberg, PhD
Stevens Institute of Technology, Hoboken, New Jersey, USA
15:15
Q&A / Panel Discussion
15:25
Break
SESSION 6: ALGORITHMS FOR FULLY AUTOMATED INSULIN DELIVERY SYSTEMS (1.0 CME Credits)
What are promising trends in controlling automated insulin delivery systems?
15:50
Moderators
Jeffrey Joseph, DO
The Artificial Pancreas Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Rayhan A. Lal, MD
Stanford University, Stanford, California, USA
Presentation of Artificial Pancreas Award
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA
15:55
Dual Closed-Loop and SGLT-2 Inhibitor Control
Ananda Basu, MD, FRCP
University of Virginia, Charlottesville, Virginia, USA
16:05
Building a Full Closed-Loop Algorithm: Insulin Timing Is the Key
Marc D. Breton, PhD
University of Virginia, Charlottesville, Virginia, USA
16:15
RocketAP in Practice: Results from Pilot and Feasibility Trials
José F. García-Tirado, PhD
University of Virginia, Charlottesville, Virginia, USA
16:25
Learning and Adaptation for Improved Control of the Artificial Pancreas
Frank J. Doyle, PhD
Harvard University, Cambridge, Massachusetts, USA
16:35
Fully Automated Insulin and Pramlintide Delivery System
Ahmad Haidar, PhD
McGill University, Montréal, Québec, Canada
16:45
Q&A / Panel Discussion
17:00
End of Session
Saturday, November 5, 2022
SESSION 7: TECHNOLOGY FOR DIAGNOSING HYPOGLYCEMIA (Non-Accredited Education)
How can new technology diagnose and prevent hypoglycemia?
8:00
Moderators
Maya Fayfman, MD
Emory University, Atlanta, Georgia, USA
Brian M. Frier, BSc, MD, FRCP
The University of Edinburgh, Edinburgh, UK
Presentation of Student Research Awards
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA
8:05
Prevention of Rebound Hypoglycemia in an Advanced Automated Insulin Delivery System
Maria F. Villa-Tamayo, MSc
University of Virginia, Charlottesville, Virginia, USA
8:20
The Role of Self-Monitoring of Blood Glucose in Diagnosing Hypoglycemia
Michelle F. Magee, MD
Georgetown University, Washington, D.C., USA; MedStar Diabetes Institute, Washington, D.C., USA
8:35
The Hypo-RESOLVE Project
Bastiaan E. de Galan, MD, PhD
Maastricht University Medical Centre, Maastricht, Netherlands; Radboud University Medical Centre, Nijmegen, Netherlands
8:50
Clinical Implications of Low Sensor Glucose
Pratik Choudhary, FRCP, MD, MRCP, MBBS
University of Leicester, Leicester, UK
9:05
EKG Diagnosis of Hypoglycemia
Sara Bachmann, MD
University Children’s Hospital Basel, Basel, Switzerland
9:20
Q&A / Panel Discussion
9:30
End of Session
SESSION 8: NOVEL INSULINS AND INSULIN DELIVERY (Non-Accredited Education)
How can technology improve insulin delivery?
9:30
Moderators
Barry H. Ginsberg, MD, PhD
Diabetes Technology Consultants, Arlington, Virginia, USA
Gerold M. Grodsky, PhD
University of California at San Francisco, San Francisco, California, USA
9:35
Tirzepatide Physiology
William C. Roell, PhD
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA
9:50
Ultralong and Ultrarapid Insulins
Tim Heise, MD
Profil Institute for Clinical Research, Neuss, Germany
10:05
Intraperitoneal Insulin Delivery
Eric Renard, MD, PhD, FRCP (Edin)
Lapeyronie Montpellier University Hospital, University of Montpellier, Montpellier, France
10:20
Advances in Smart Pens and Caps for Insulin Delivery
Johan H. Jendle, MD, PhD
Örebro University Hospital, Örebro, Sweden
10:35
Q&A / Panel Discussion
10:50
Break
SESSION 9: NOVEL ON-BODY SENSORS FOR DIABETES (Non-Accredited Education)
What are promising new types of sensors and measurements of interest for monitoring diabetes?
11:15
Moderators
Rodolfo J. Galindo, MD, FACE
Emory University, Atlanta, Georgia, USA
Irl B. Hirsch, MD, MACP
University of Washington, Seattle, Washington, USA
11:20
Measurement of Sweat Glucose and Lactate
Joseph Wang, PhD
University of California, San Diego, San Diego, California, USA
11:30
Sleep Sensors for Monitoring Diabetes
Ali Cinar, PhD
Illinois Institute of Technology, Chicago, Illinois, USA
11:40
Cardiac Autonomic Neuropathy Sensors for Diabetes
Christian S. Hansen, MD, PhD
Steno Diabetes Center Copenhagen, Birkerød, Denmark
11:50
EEG Findings in Hypoglycemia
Maria Rubega, PhD
University of Padova, Padova, Italy
12:00
Q&A / Panel Discussion
12:10
Lunch
SESSION 10: ADVANCES IN CGM TECHNOLOGY (Non-Accredited Education)
What are important advances in CGM technology contained in commercial products?
12:55
Moderators
Geoff Chase, PhD
University of Canterbury, Christchurch, New Zealand
Hubert W. Vesper, PhD
Centers for Disease Control and Prevention, Atlanta, Georgia, USA
13:00
Abbott Technology
Marc B. Taub, PhD
Abbott Diabetes Care, Alameda, California, USA
13:12
Dexcom Technology
Peter Simpson, MS
Dexcom Inc., San Diego, California, USA
13:24
Medtronic Technology
Robert Vigersky, MD
Medtronic, Washington, D.C., USA; Uniformed Services University of the Health Sciences, Bethesda, Maryland, US
13:36
Senseonics Technology
Francine R. Kaufman, MD
Senseonics Inc., Germantown, Maryland, USA
13:48
Q&A / Panel Discussion
14:10
End of Session
SESSION 11: DIGITAL HEALTH TOOLS TO PREVENT DIABETIC FOOT ULCERS: ACHIEVING SUCCESS BY UNDERSTANDING DEFEAT (Non-Accredited Education)
What types of sensing and treatment technologies can improve outcomes for foot ulcers in diabetes?
14:10
Moderators
David G. Armstrong, DPM, MD, PhD
University of Southern California, Los Angeles, California, USA
Bijan Najafi, PhD, MSc
Baylor College of Medicine, Houston, Texas, USA
14:15
National Science Foundation’s Center to Stream Healthcare in Place (C2SHiP.org)
David G. Armstrong, DPM, MD, PhD
University of Southern California, Los Angeles, California, USA
14:25
Digital Health-led Decentralization for Managing Diabetic Foot Syndrome
Bijan Najafi, PhD, MSc
Baylor College of Medicine, Houston, Texas, USA
14:35
Noninvasive Monitoring for Tissue Oxygenation
Anuradha Godavarty, PhD
Florida International University, Miami, Florida, USA
14:45
Q&A / Panel Discussion
14:55
Break
SESSION 12: HOT TOPICS (0.75 CME Credits)
What are some emerging areas of interest in the field of diabetes technology?
15:20
Moderators
Halis K. Aktürk, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA
Umesh Masharani, MD
University of California, San Francisco, San Francisco, California, USA
15:25
Diabetes and the Environment
Sultan A. Meo, MD, MBBS, PhD, FRCP
King Saud University College of Medicine, Riyadh, Saudi Arabia
15:35
Diabetes Technology and the Environment
Lutz Heinemann, PhD
Science Consulting in Diabetes, Kaarst, Germany
15:45
Spinal Cord Stimulation for Painful Diabetic Neuropathy
Erika A. Petersen, MD, FAANS, FACS
University of Arkansas, Little Rock, Arkansas, USA
15:55
Q&A / Panel Discussion
16:05
End of Session
LIVE DEMONSTRATION (0.25 CME Credits)
How does a new product with novel technology function?
16:05
Moderators
Dorian Liepmann, PhD
University of California, Berkeley, Berkeley, California, USA
Jane Jeffrie Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES, CDTC, FADCES
Weill Cornell Medicine, New York, New York, USA
16:10
A Novel Product For Greener Diabetes Technology
Brian Brandell, PhD, MBA
Hemingway Designs LLC, Oregon City, Oregon, USA
Colt Stuart, BSME
Hemingway Designs LLC, Oregon City, Oregon, USA
16:25
Q&A
16:30
Closing Statements
Wednesday, November 9, 2022
PRODUCT THEATERS (Non-Accredited Education)
10:00
MannKind Product Theater: Ready. Set. Inhale: Clinical Update on AfrezzaFree Recording
Jennifer T. Rittenberry, MD, FACE
MannKind, Westlake Village, California, USA
10:30
Dexcom Product Theater: Introducing the all new Dexcom G7Free Recording
Grazia Aleppo, MD, FACE, FACP
Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
11:30
End of Product Theater Sessions
Thursday, November 10, 2022
Poster Sessions (Non-Accredited education)Free Recording
Moderators
John C. Pickup, MA, DPhil, FRCPath
King’s College London School of Medicine, London, UK
Jane Jeffrie Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES, CDTC, FADCES
Weill Cornell Medicine, New York, New York, USA
8:30 Use of Ultra-Rapid Insulin Lispro with a Full Closed-Loop Insulin Delivery System: An In Silico Analysis
Jenny L. Diaz C., PhD, et al.
Presented by: Patricio Colmegna, PhD
8:34 Simdex Enables First-in-Human Trials of a Novel Automated Insulin Delivery System at Home
Stephen Patek, PhD
8:38 Prevention of Rebound Hypoglycemia in an Advanced Automated Insulin Delivery System
Maria Fernanda Villa-Tamayo, MS
8:42 Comparing Different Individualized Black-Box Models for Insulin Pump Faults Detection on Artificial Pancreas Data
Eleonora Manzoni, MSc et al.
8:46 Feasibility of a Prototype Dual Function Glucose Sensing and Insulin Delivering Cannula
Cheng Yi Yuan, MD et al.
8:50 Significant Reduction in Hyperglycemia and High Satisfaction with Use of Control-IQ Technology in Prior MDI and Basal-Only Insulin Users with Type 2 Diabetes
Carol J. Levy, MD, CDCES et al.
8:54 Q&A / Panel Discussion
9:15 End of Session
Moderators
Bruce Buckingham, MD
Stanford University, Stanford, California, USA
Jenise C. Wong, MD, PhD
University of California, San Francisco, San Francisco, California, USA
9:15 Once-Weekly Insulin Icodec vs Once-Daily Insulin Glargine U100 in Combination with Bolus Insulin in Individuals with Type 2 Diabetes on Basal-Bolus Regimens (ONWARDS 4)
Chantal Mathieu, MD, PhD et al.
9:19 A Novel Infusion Failure Detection Paradigm Based on Fluid Pressure and Supervised Learning
Luis E. Blanco, BChE et al.
9:23 Insulin Pump Disruption: Cause and Effect
Alexander M. Markov, MD et al.
9:27 In Vitro Validation of an Open Source, Ultra-Low-Cost (<US$100) Insulin Pump
Matthew Payne, BE(Hons) et al.
9:31 Ultra Low Cost, Ultra Low Power, Open Source Clockwork Insulin Pump
Francis Pooke, BE(Hons) et al.
9:35 Inhaled Insulin + AID Safely Reduced Glucose in the 2 Hours Following a Meal in Proof-of-Concept Study Data Subset
Kevin Kaiserman, MD et al.
9:39 Q&A / Panel Discussion
10:00 End of Session
Moderators
Ibrahim A. Hashim, MSc, PhD, DABCC, FIBMS, CSc, FACB
UT Southwestern, Dallas, Texas, USA
Andreas Thomas, PhD
Freelance Scientific Consultant, Pirna, Germany
10:00 Next Generation Glucose Reference Platform - Data Supporting the Use of the Radiometer ABL90 Analyzer
Alejandra M. Pulido, MD et al.
10:04 Machine Learning Based Models for Estimating CGM Accuracy to Venous Plasma Glucose from Accuracy to Capillary Glucose
Arnaud Jacquin, PhD et al.
10:08 User Performance Evaluation and System Accuracy Assessment of Four Blood Glucose Monitoring Systems With Color Coding of Results
Stefan Pleus, MSc et al.
10:12 Open Access, Light Based, Wearable Glucose Sensor – a Low-Cost Equitable APS
Josephine A. Dixon, BE(Hons) et al.
10:16 Comparison of POCT Devices to Glucose Isotope Dilution Gas Chromatography - Mass Spectrometry Reference Measurement Procedure
Komal Dahya, BS et al.
10:20 Improving the Quality of Glucose Concentration Measurements by Recalibration
Stefan Pleus, MSc et al.
10:24 Q&A / Panel Discussion
10:45 End of Session
Moderators
Julia Mader, MD
Medical University of Graz, Graz, Germany
Viral N. Shah, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA
10:45 Real-World Digital Health Data Demonstrate the Utility of The Glycemia Risk Index (GRI) as a Composite CGM Metric
Junjie Luo, PhD et al.
Presented by: Mansur Shomali, MD, CM
10:49 Imputation Model for Glucose Values Out of Measuring Range for Continuous Glucose Monitoring
Mikkel T. Olsen, MD et al.
10:53 Development of Derivatization-Free ID-LC/MS/MS Method for Simultaneous Measurement of Human Serum Monosaccharides
Chui Y. Tse, MS et al.
10:57 Translating event history to expected glucose distribution
Mrunal Sontakke, B.S et al.
11:01 The Continuous Glucose Deviation Interval and Variability Analysis (CG-DIVA): An Illustrative Method for Continuous Glucose Monitoring System Accuracy Assessment
Manuel Eichenlaub, PhD et al.
11:05 Delivering Insulin by Glucose-Responsive Polymer-Based Microneedle Patch
Jackie F. Liu, B.Tech et al.
11:09 Q&A / Panel Discussion
11:30 End of Session
Moderators
Guillermo A. Arreaza-Rubin, MD
NIDDK/NIH, Bethesda, Maryland, USA
Robert Gabbay, MD, PhD
American Diabetes Association, Arlington, Virginia, USA
11:30 Smart Insulin Therapy Initiation in Insulin-Naïve Subjects with Type 2 Diabetes Using Machine Learning
Jacopo Bonet, MS et al.
11:34 Long-Term Glycemic and Patient-Reported Outcomes in Older Adults with Type 1 Diabetes Using Control-IQ Technology
Steph Habif, EdD, MS et al.
11:38 Diabetes Phenotypes Quantified via a Physiofunctional Model Fitted to Raw CGM Time Series Data
Robert Capps, PhD et al.
11:42 Simulating the Impact of Diabetes Therapy Engagement on Outcomes
Lane Desborough, MScEng et al.
11:46 Correlation of Hemoglobin A1c and Continuous Glucose Monitor Metrics in Diverse Populations of Youth with Diabetes
Meryl Nath, BA et al.
11:50 InPen™ System Use and Glycemic Outcomes in Older Adults
Glen H. Im, MS et al.
11:54 Q&A / Panel Discussion
12:15 End of Session
Moderators
Ananda Basu, MD, FRCP
University of Virginia, Charlottesville, Virginia, USA
Sultan A. Meo, MD, MBBS, PhD, FRCP
King Saud University College of Medicine, Riyadh, Saudi Arabia
12:15 Effect of Mobile Application Usage on TIR and TAR Within People with T1D and T2D: A Pilot Cohort Retrospective Study
Mikhalina Akulova, MSc et al.
12:19 Smartphone Camera to Image the Retina for Primary Care MDs and Diabetologists
Ethan Hintz et al.
12:23 Free Diabetes Apps and Health Literacy for Diabetic Patients
Kayla Israni et al.
12:27 Social Network Analysis of Diabetes and Glucose Monitoring Systems on Twitter Informed by ADCES7™ Framework
Nishant R. Jain, MS et al.
12:31 The Use of a Combined Real-Time CGM and Digital Health Solution Lowered A1C in People With Type 2 Diabetes
Abhimanyu Kumbara et al.
12:35 Sensor Controlled Diabetic Foot Ulcer Therapy – Next Generation Therapy of the Most Devastating Complication of Diabetes
Dirk Hochlenert, MD, PhD et al.
12:39 Q&A / Panel Discussion
13:00 End of Session